Ivosidenib for advanced IDH1-mutant cholangiocarcinoma

被引：0
|
作者：
Gervaso, Lorenzo [1 ]
Pellicori, Stefania [1 ]
Fazio, Nicola [1 ]
机构：
[1] European Inst Oncol, Div Gastrointestinal Med Oncol & Neuroendocrine T, I-20141 Milan, Italy
来源：
LANCET ONCOLOGY | 2020年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E370 / E370
页数：1
相关论文
共 50 条
  • [31] Spikes induced by IDH1-mutant gliomas
    Abounader, Roger
    Wright, Karen
    Bhat, Krishna
    Chamberlain, Marc
    Purow, Benjamin
    Soffietti, Riccardo
    NEURO-ONCOLOGY, 2017, 19 (10) : 1295 - 1296
  • [32] EXPOSURE-RESPONSE ANALYSIS OF IVOSIDENIB IN PATIENTS WITH IDH1-MUTANT RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA.
    Le, K.
    Kleijn, H. J.
    Dai, D.
    Fan, B.
    Liu, H.
    Attar, E. C.
    Hickman, D.
    Agresta, S. V.
    Yang, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S85 - S85
  • [33] Pharmacokinetics/pharmacodynamics (PK/PD) of ivosidenib in patients with mutant IDH1 advanced cholangiocarcinoma from the phase III ClarIDHy study
    Fan, Bin
    Abou-Alfa, Ghassan K.
    Zhu, Andrew X.
    Pandya, Shuchi Sumant
    Jia, Hongxia
    Yin, Feng
    Jiang, Liewen
    Gliser, Camelia
    Yang, Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [34] A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN
    Xiao, Wenbin
    Miles, Linde A.
    Bowman, Robert L.
    Durani, Vidushi
    Tian, Helen S.
    DelGaudio, Nicole L.
    Mishra, Tanmay
    Zhu, Menglei
    Zhang, Yanming
    Stump, Sarah E.
    Tallman, Martin S.
    Levine, Ross L.
    Cai, Sheng F.
    BLOOD ADVANCES, 2020, 4 (23) : 6034 - 6038
  • [35] Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
    Ingo K. Mellinghoff
    Min Lu
    Patrick Y. Wen
    Jennie W. Taylor
    Elizabeth A. Maher
    Isabel Arrillaga-Romany
    Katherine B. Peters
    Benjamin M. Ellingson
    Marc K. Rosenblum
    Saewon Chun
    Kha Le
    Ania Tassinari
    Sung Choe
    Youssef Toubouti
    Steven Schoenfeld
    Shuchi S. Pandya
    Islam Hassan
    Lori Steelman
    Jennifer L. Clarke
    Timothy F. Cloughesy
    Nature Medicine, 2024, 30 : 302 - 302
  • [36] Ivosidenib in the treatment of patients with IDH1 mutated cholangiocarcinoma
    Chmielewska, Agnieszka
    Kubiatowski, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 286 - 290
  • [37] Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
    Abou-Alfa, Ghassan K.
    Macarulla, Teresa
    Javle, Milind M.
    Kelley, Robin K.
    Lubner, Sam J.
    Adeva, Jorge
    Cleary, James M.
    Catenacci, Daniel V.
    Borad, Mitesh J.
    Bridgewater, John
    Harris, William P.
    Murphy, Adrian G.
    Oh, Do-Youn
    Whisenant, Jonathan
    Lowery, Maeve A.
    Goyal, Lipika
    Shroff, Rachna T.
    El-Khoueiry, Anthony B.
    Fan, Bin
    Wu, Bin
    Chamberlain, Christina X.
    Jiang, Liewen
    Gliser, Camelia
    Pandya, Shuchi S.
    Valle, Juan W.
    Zhu, Andrew X.
    LANCET ONCOLOGY, 2020, 21 (06): : 796 - 807
  • [38] Molecular Mechanisms Mediating Relapse Following Ivosidenib Monotherapy in Patients with IDH1-Mutant Relapsed or Refractory Acute Myeloid Leukemia
    Choe, Sung
    Wang, Hongfang
    DiNardo, Courtney D.
    Stein, Eytan M.
    De Botton, Stephane
    Fathi, Amir T.
    Tallman, Martin S.
    Kantarjian, Hagop M.
    Stone, Richard M.
    Quek, Lynn
    Konteatis, Zenon
    Dang, Lenny
    Zhang, Vickie
    Liu, Hua
    Attar, Eyal C.
    Wu, Bin
    BLOOD, 2019, 134
  • [39] Ivosidenib (IVO; AG-120) in IDH1-Mutant Relapsed or Refractory Myelodysplastic Syndrome: Updated Results from a Phase 1 Study
    DiNardo, Courtney D.
    Foran, James M.
    Watts, Justin M.
    Stein, Eytan M.
    De Botton, Stephane
    Fathi, Amir T.
    Prince, Gabrielle T.
    Stein, Anthony S.
    Stone, Richard M.
    Patel, Prapti A.
    Tallman, Martin S.
    Choe, Sung
    Wang, Hongfang
    Zhang, Vickie
    Dai, David
    Fan, Bin
    Yen, Katherine E.
    Kapsalis, Stephanie K.
    Hickman, Denice
    Agresta, Samuel V.
    Liu, Hua
    Wu, Bin
    Attar, Eyal C.
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S340 - S340
  • [40] Ivosidenib: A Review in Advanced Cholangiocarcinoma
    Frampton, James E.
    TARGETED ONCOLOGY, 2023, 18 (06) : 973 - 980
12345